<DOC>
	<DOCNO>NCT02654288</DOCNO>
	<brief_summary>Investigators previously find infiltration immunoglobulin G4 ( IgG4 ) positive plasma cell tumor tissue predicts poor prognosis pancreatic cancer curative resection . Investigators attempt explore possible role IgG4 inducer IgG4 , interleukin-10 ( IL-10 ) , chemotherapy pancreatic cancer . In primary study , investigator plan observe dynamic change sera IgG4 IL-10 peripheral blood gemcitabine-based chemotherapy analyze correlation IgG4 IL-10 response gemcitabine overall survival pancreatic cancer .</brief_summary>
	<brief_title>Dynamic Changes Sera Immunoglobulin G4 Interleukin-10 Patients Pancreatic Cancer After Chemotherapy</brief_title>
	<detailed_description>Human immunoglobulin G ( IgG ) family consist four member , IgG1 , IgG2 , IgG3 IgG4.IgG4 regard inhibitory IgG inhibit activation immune response [ 1 ] . Recently report IgG4 could weaken activation macrophage promote cancer progression [ 2 ] . Autoimmune pancreatitis ( AIP ) common clinical manifestation IgG4-related sclerosing disease ( IRSD ) characterize abundant infiltration IgG4 positive plasma cell [ 3 ] .Although abundant infiltration IgG4 positive plasma cell pancreatic lesion AIP , correlation IgG4 positive plasma cell pancreatic cancer never reported.Investigators previously find high level infiltration IgG4 positive plasma cell tumor tissue predicts poor prognosis pancreatic cancer curative resection ( publish ) .Investigators attempt explore possible role IgG4 inducer IgG4 , IL-10 , chemotherapy pancreatic cancer.Since gemcitabine first line chemotherapeutic drug pancreatic cancer , primary study , investigator plan observe dynamic change sera IgG4 IL-10 peripheral blood gemcitabine-based chemotherapy analyze correlation IgG4 IL-10 response gemcitabine overall survival pancreatic cancer .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulin G</mesh_term>
	<criteria>1 . Age range 18 75year old ; 2 . Pathological verify pancreatic cancer include adenocarcinoma cancerogenesis intraductal papillary mucinous neoplasm ( IPMN ) ; 3 . Pancreatic cancer patient receive adjuvant chemotherapy curative resection ; pancreatic cancer patient recurrent lesion receive chemotherapy curative resection ; pancreatic cancer patient unresectable tumor receive chemotherapy ; 4 . Patients good physical status receive chemotherapy ; 5 . No history chemotherapy current regimen contains gemcitabine ; 6 . No medical history IgG4 related disease connective tissue disease ; 7 . Written consent available . 1 . Patient young 18year old ; 2 . Patient chemotherapy ; 3 . The physical status poor receive chemotherapy ; 4 . The patient history IgG4 related disease connective disease ; 5 . Written consent available .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>pancreatic cancer</keyword>
	<keyword>gemcitabine</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>immunoglobulin G 4</keyword>
</DOC>